News & Press

     

Evogene Strengthens its Scientific & Business Management Teams

     
August 30th, 2006

Rehovot, Israel – August 30, 2006 – Evogene announces that during the first half of 2006 it significantly strengthened its scientific and business management capabilities.

Following its successful $7 second capital raising announced in March 2006, in order to continue the development of its computational biology tools and to support its growing pipeline of collaborations both signed and currently being negotiated, Evogene made significant additions to its scientific and business management teams during the first half of 2006.

The most significant additions to the Evogene team are mentioned below:

Mr. Assaf Oron: Director of Strategy and Business Development

Mr. Oron has a mixed business and scientific background. Prior to joining Evogene, was managing ChondroSite Ltd., a biotechnology company developing tissue engineered products in the field of Orthopedics (2004-2006). Mr. Oron has over 5 years of experience in strategic consulting at POC Ltd., a leading Israeli management consulting company, where he served as senior project manager working with leading companies in the Israeli industry.

Mr. Oron holds a M.Sc. in Biology and B.Sc. degrees in Economics and Chemistry from Tel Aviv University.

Dr Tamara Byk-Tennenbaum: Director of the Technology Platform

Prior to joining Evogene, Dr Byk has held management and research positions in the biotechnology industry in Israel as Head of the Life Science Research Unit at Procognia (2004-2006), and senior researcher at Quark Biotech Inc (QBI) (2000-2004). Dr Byk held various research and post doctoral positions including at the Weizmann Institute (Israel), and two INSERM research laboratories in Paris and Villejuif (France) (1992-2000).

Dr Byk holds a Ph.D. (1992) and a M.Sc. (1986) in Biochemistry as well as a B.Sc. in chemistry (1983) from the Hebrew University of Jerusalem.

Dr Eyal Emmanuel: Program Director - Biodiesel

Prior to joining Evogene, Dr Emmanuel worked as a researcher at the Life Science Research Israel Co. In parallel, with his studies Dr Emmanuel also participated in commercial pepper breeding projects of the Faculty of Agriculture of the Hebrew University of Jerusalem (1995-1998) and also performed bioinformatics and data mining projects for Evogene (2001-2003).

Dr Emmanuel holds a Ph.D. (2005) and a M.Sc. (2000) from the Department of Plant Science of the Weizmann Institute as well as a B.Sc. from the Faculty of Agriculture of the Hebrew University.

Mr. Alex Diber: Department Manager - Computational Genomics

Prior to joining Evogene, Mr. Diber worked for 12 years at Compugen joining the company in 1994 as one of its early employees initially as Software Engineer then evolving to Team Leader, Software Architect and in the last 6 years as Senior Bioinformatics Scientist. Mr Diber has been leading research projects related to integration and analysis of multiple data sources like genomic, expression, chip, pathway, protein-protein interaction and drug-related data.

Mr Diber holds a B.A. in Computer Science for the University Ben Gurion University of the Negev (Cum Laude).

Dr Ron Vunsh: Tissue Culture & Plant Transformation

Prior to joining Evogene, Dr Vunsh was Senior Scientist at Fertiseed (2005-2006), the manager of the “Plant Transformation Center” of the Weizmann Institute (1995-2005), Senior Scientist and Manager of a commercial banana micropropagation laboratory owned by Rahan Meristem (1993-1995), Research Associate at the Volcani Institute (1989-1991), Scientific Manager of A.L. Research and development a plant micropropagation company (1987-1989) and Senior Scientist and Scientific Manager of the “International Genetic Sciences Partnership” (1983-1987).

Dr Vunsh holds a Ph.D. (1981) from the Department of Plant Science of the Weizmann Institute, a M.Sc. in Biochemistry (1976) and a B.Sc. in Chemistry (1972) from the University of Tel Aviv. Dr Vunsh also performed post-doctoral research at the University of Illinois (1981-1983).

Ofer Haviv, President and CEO for Evogene stated: “We are pleased to welcome such talented and experienced individuals to strengthen our team and ramp up our capabilities at a time where we are expanding our research pipeline and starting to sign significant partnerships”. I am certain each and every one of these individuals will significantly contribute to Evogene’s development.

print page

Latest News:



2010

2009

2008

2007

2006

2005

2004

2003

2002
© Evogene ltd. Design by: Bee-Creations   Code by: FATLADY